Published • loading... • Updated
Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer
Summary by Optimum Strategic Communications
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer
Lund, Sweden, 15 June 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) announced today the appointment of Adam Cutler as Chief Financial Officer (CFO) and a member of the Executive Committee, effective June 22, 2026. Adam succeeds Evan Ballantyne, who has served as CFO since 2024. Evan will continue in the role until June 22 […] The post Hansa Biopharma appoints Adam Cutler as new Chief Financial Officer appeared first on Optimum Stra…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
